The aim of this study was to establish a multidisciplinary assisted diagnosis and treatment model for patients at high risk of cardioembolic stroke, manage and collect the diagnosis, treatment and prognosis data of patients. Around 1,200 patients at high-risk of cardioembolic stroke were enrolled into the study from September 2022 to September 2023 from the Second Affiliated Hospital of Nanchang University and sub-centers of hospitals at all levels in Jiangxi Province, China.
Study design
Registry, Cohort - clinical
Number of participants at first data collection
~1,200 (participants)
Age at first data collection
Varied (participants)
Participant year of birth
Varied (participants)
Participant sex
All
Representative sample at baseline?
No
Sample features
Country
Year of first data collection
2022
Primary Institutions
Second Affiliated Hospital of Nanchang University (南昌大学第二附属医院, SAHNU)
Profile paper DOI
Not available
Funders
No funding information available
Ongoing?
Yes
Data types collected
Engagement
Keywords